Skip Nav Destination
Checking in: T cells against multiple myeloma
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
Analysis of the recovery of CD247 expression in a PID patient: insights into the spontaneous repair of defective genes
Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry
Issue Archive
September 7 2017
In this Issue
Table of Contents
INSIDE BLOOD COMMENTARIES
INSIDE BLOOD COMMENTARY
Checking in: T cells against multiple myeloma
Clinical Trials & Observations
REVIEW ARTICLE
CLINICAL TRIALS AND OBSERVATIONS
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma
Clinical Trials & Observations
Ashraf Badros,Elizabeth Hyjek,Ning Ma,Alexander Lesokhin,Ahmet Dogan,Aaron P. Rapoport,Mehmet Kocoglu,Emily Lederer,Sunita Philip,Todd Milliron,Cameron Dell,Olga Goloubeva,Zeba Singh
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma
Clinical Trials & Observations
Jonas Paludo,Joseph R. Mikhael,Betsy R. LaPlant,Alese E. Halvorson,Shaji Kumar,Morie A. Gertz,Suzanne R. Hayman,Francis K. Buadi,Angela Dispenzieri,John A. Lust,Prashant Kapoor,Nelson Leung,Stephen J. Russell,David Dingli,Ronald S. Go,Yi Lin,Wilson I. Gonsalves,Rafael Fonseca,P. Leif Bergsagel,Vivek Roy,Taimur Sher,Asher A. Chanan-Khan,Sikander Ailawadhi,A. Keith Stewart,Craig B. Reeder,Paul G. Richardson,S. Vincent Rajkumar,Martha Q. Lacy
IMMUNOBIOLOGY AND IMMUNOTHERAPY
Analysis of the recovery of CD247 expression in a PID patient: insights into the spontaneous repair of defective genes
Brief Report
Alfonso Blázquez-Moreno,Adriana Pérez-Portilla,Miriam Agúndez-Llaca,Daniela Dukovska,Mar Valés-Gómez,Cigdem Aydogmus,Aydan Ikinciogullari,José R. Regueiro,Hugh T. Reyburn
LYMPHOID NEOPLASIA
Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry
Clinical Trials & Observations
Brief Report
Takaya Moriyama,Yung-Li Yang,Rina Nishii,Hany Ariffin,Chengcheng Liu,Ting-Nien Lin,Wenjian Yang,Dong-Tsamn Lin,Chih-Hsiang Yu,Shirley Kham,Ching-Hon Pui,William E. Evans,Sima Jeha,Mary V. Relling,Allen Eng-Juh Yeoh,Jun J. Yang
MYELOID NEOPLASIA
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
The atypical receptor CCRL2 is required for CXCR2-dependent neutrophil recruitment and tissue damage
Annalisa Del Prete,Laura Martínez-Muñoz,Cristina Mazzon,Lara Toffali,Francesca Sozio,Lorena Za,Daniela Bosisio,Luisa Gazzurelli,Valentina Salvi,Laura Tiberio,Chiara Liberati,Eugenio Scanziani,Annunciata Vecchi,Carlo Laudanna,Mario Mellado,Alberto Mantovani,Silvano Sozzani
PLATELETS AND THROMBOPOIESIS
RED CELLS, IRON, AND ERYTHROPOIESIS
TRANSFUSION MEDICINE
TRANSPLANTATION
LETTERS TO BLOOD
Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes
Bruno Tesson,Sarah Huet,Béatrice Grange,Laurent Jallades,Lucile Baseggio,Pascale Felman,Alexandra Traverse-Glehen,Jean-Pierre Magaud,Jean-Christophe Lega,Christine Bole-Feysot,Gilles Salles,Evelyne Callet-Bauchu,Pierre Sujobert
BLOOD WORK
-
Cover Image
Cover Image
![issue cover]()
Three-dimensional structure of the human NUDT15 protein. Green and cyan indicate chain A and B in the NUDT15 homodimer. Red and blue colors highlight amino acid residues affected by genetic polymorphisms that are related to thiopurine drug toxicity in patients. The NUDT15 substrate thioguanine monophosphate is shown in a stick-ball representation. See the article by Moriyama et al on page 1209.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
